1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Nanobiotechnology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Nanomedicine 1.2.3 Nano Medical Devices 1.2.4 Nano Diagnosis 1.2.5 Other 1.3 Market by Application 1.3.1 Global Nanobiotechnology Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Anticancer 1.3.3 CNS Product 1.3.4 Anti-infective 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Nanobiotechnology Market Perspective (2017-2028) 2.2 Nanobiotechnology Growth Trends by Region 2.2.1 Nanobiotechnology Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Nanobiotechnology Historic Market Size by Region (2017-2022) 2.2.3 Nanobiotechnology Forecasted Market Size by Region (2023-2028) 2.3 Nanobiotechnology Market Dynamics 2.3.1 Nanobiotechnology Industry Trends 2.3.2 Nanobiotechnology Market Drivers 2.3.3 Nanobiotechnology Market Challenges 2.3.4 Nanobiotechnology Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Nanobiotechnology Players by Revenue 3.1.1 Global Top Nanobiotechnology Players by Revenue (2017-2022) 3.1.2 Global Nanobiotechnology Revenue Market Share by Players (2017-2022) 3.2 Global Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Nanobiotechnology Revenue 3.4 Global Nanobiotechnology Market Concentration Ratio 3.4.1 Global Nanobiotechnology Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Nanobiotechnology Revenue in 2021 3.5 Nanobiotechnology Key Players Head office and Area Served 3.6 Key Players Nanobiotechnology Product Solution and Service 3.7 Date of Enter into Nanobiotechnology Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Nanobiotechnology Breakdown Data by Type 4.1 Global Nanobiotechnology Historic Market Size by Type (2017-2022) 4.2 Global Nanobiotechnology Forecasted Market Size by Type (2023-2028) 5 Nanobiotechnology Breakdown Data by Application 5.1 Global Nanobiotechnology Historic Market Size by Application (2017-2022) 5.2 Global Nanobiotechnology Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Nanobiotechnology Market Size (2017-2028) 6.2 North America Nanobiotechnology Market Size by Country (2017-2022) 6.3 North America Nanobiotechnology Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Nanobiotechnology Market Size (2017-2028) 7.2 Europe Nanobiotechnology Market Size by Country (2017-2022) 7.3 Europe Nanobiotechnology Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Nanobiotechnology Market Size (2017-2028) 8.2 Asia-Pacific Nanobiotechnology Market Size by Country (2017-2022) 8.3 Asia-Pacific Nanobiotechnology Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Nanobiotechnology Market Size (2017-2028) 9.2 Latin America Nanobiotechnology Market Size by Country (2017-2022) 9.3 Latin America Nanobiotechnology Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Nanobiotechnology Market Size (2017-2028) 10.2 Middle East & Africa Nanobiotechnology Market Size by Country (2017-2022) 10.3 Middle East & Africa Nanobiotechnology Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Amgen 11.1.1 Amgen Company Detail 11.1.2 Amgen Business Overview 11.1.3 Amgen Nanobiotechnology Introduction 11.1.4 Amgen Revenue in Nanobiotechnology Business (2017-2022) 11.1.5 Amgen Recent Development 11.2 Teva Pharmaceuticals 11.2.1 Teva Pharmaceuticals Company Detail 11.2.2 Teva Pharmaceuticals Business Overview 11.2.3 Teva Pharmaceuticals Nanobiotechnology Introduction 11.2.4 Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2017-2022) 11.2.5 Teva Pharmaceuticals Recent Development 11.3 Abbott 11.3.1 Abbott Company Detail 11.3.2 Abbott Business Overview 11.3.3 Abbott Nanobiotechnology Introduction 11.3.4 Abbott Revenue in Nanobiotechnology Business (2017-2022) 11.3.5 Abbott Recent Development 11.4 UCB 11.4.1 UCB Company Detail 11.4.2 UCB Business Overview 11.4.3 UCB Nanobiotechnology Introduction 11.4.4 UCB Revenue in Nanobiotechnology Business (2017-2022) 11.4.5 UCB Recent Development 11.5 Roche 11.5.1 Roche Company Detail 11.5.2 Roche Business Overview 11.5.3 Roche Nanobiotechnology Introduction 11.5.4 Roche Revenue in Nanobiotechnology Business (2017-2022) 11.5.5 Roche Recent Development 11.6 Celgene 11.6.1 Celgene Company Detail 11.6.2 Celgene Business Overview 11.6.3 Celgene Nanobiotechnology Introduction 11.6.4 Celgene Revenue in Nanobiotechnology Business (2017-2022) 11.6.5 Celgene Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Detail 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Nanobiotechnology Introduction 11.7.4 Sanofi Revenue in Nanobiotechnology Business (2017-2022) 11.7.5 Sanofi Recent Development 11.8 Merck & Co 11.8.1 Merck & Co Company Detail 11.8.2 Merck & Co Business Overview 11.8.3 Merck & Co Nanobiotechnology Introduction 11.8.4 Merck & Co Revenue in Nanobiotechnology Business (2017-2022) 11.8.5 Merck & Co Recent Development 11.9 Biogen 11.9.1 Biogen Company Detail 11.9.2 Biogen Business Overview 11.9.3 Biogen Nanobiotechnology Introduction 11.9.4 Biogen Revenue in Nanobiotechnology Business (2017-2022) 11.9.5 Biogen Recent Development 11.10 Stryker 11.10.1 Stryker Company Detail 11.10.2 Stryker Business Overview 11.10.3 Stryker Nanobiotechnology Introduction 11.10.4 Stryker Revenue in Nanobiotechnology Business (2017-2022) 11.10.5 Stryker Recent Development 11.11 Gilead Sciences 11.11.1 Gilead Sciences Company Detail 11.11.2 Gilead Sciences Business Overview 11.11.3 Gilead Sciences Nanobiotechnology Introduction 11.11.4 Gilead Sciences Revenue in Nanobiotechnology Business (2017-2022) 11.11.5 Gilead Sciences Recent Development 11.12 Pfizer 11.12.1 Pfizer Company Detail 11.12.2 Pfizer Business Overview 11.12.3 Pfizer Nanobiotechnology Introduction 11.12.4 Pfizer Revenue in Nanobiotechnology Business (2017-2022) 11.12.5 Pfizer Recent Development 11.13 3M Company 11.13.1 3M Company Company Detail 11.13.2 3M Company Business Overview 11.13.3 3M Company Nanobiotechnology Introduction 11.13.4 3M Company Revenue in Nanobiotechnology Business (2017-2022) 11.13.5 3M Company Recent Development 11.14 Johnson & Johnson 11.14.1 Johnson & Johnson Company Detail 11.14.2 Johnson & Johnson Business Overview 11.14.3 Johnson & Johnson Nanobiotechnology Introduction 11.14.4 Johnson & Johnson Revenue in Nanobiotechnology Business (2017-2022) 11.14.5 Johnson & Johnson Recent Development 11.15 Smith & Nephew 11.15.1 Smith & Nephew Company Detail 11.15.2 Smith & Nephew Business Overview 11.15.3 Smith & Nephew Nanobiotechnology Introduction 11.15.4 Smith & Nephew Revenue in Nanobiotechnology Business (2017-2022) 11.15.5 Smith & Nephew Recent Development 11.16 Leadiant Biosciences 11.16.1 Leadiant Biosciences Company Detail 11.16.2 Leadiant Biosciences Business Overview 11.16.3 Leadiant Biosciences Nanobiotechnology Introduction 11.16.4 Leadiant Biosciences Revenue in Nanobiotechnology Business (2017-2022) 11.16.5 Leadiant Biosciences Recent Development 11.17 Kyowa Hakko Kirin 11.17.1 Kyowa Hakko Kirin Company Detail 11.17.2 Kyowa Hakko Kirin Business Overview 11.17.3 Kyowa Hakko Kirin Nanobiotechnology Introduction 11.17.4 Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2017-2022) 11.17.5 Kyowa Hakko Kirin Recent Development 11.18 Shire 11.18.1 Shire Company Detail 11.18.2 Shire Business Overview 11.18.3 Shire Nanobiotechnology Introduction 11.18.4 Shire Revenue in Nanobiotechnology Business (2017-2022) 11.18.5 Shire Recent Development 11.19 Ipsen 11.19.1 Ipsen Company Detail 11.19.2 Ipsen Business Overview 11.19.3 Ipsen Nanobiotechnology Introduction 11.19.4 Ipsen Revenue in Nanobiotechnology Business (2017-2022) 11.19.5 Ipsen Recent Development 11.20 Endo International 11.20.1 Endo International Company Detail 11.20.2 Endo International Business Overview 11.20.3 Endo International Nanobiotechnology Introduction 11.20.4 Endo International Revenue in Nanobiotechnology Business (2017-2022) 11.20.5 Endo International Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Nanobiotechnology Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Nanomedicine Table 3. Key Players of Nano Medical Devices Table 4. Key Players of Nano Diagnosis Table 5. Key Players of Other Table 6. Global Nanobiotechnology Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Nanobiotechnology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Nanobiotechnology Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Nanobiotechnology Market Share by Region (2017-2022) Table 10. Global Nanobiotechnology Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Nanobiotechnology Market Share by Region (2023-2028) Table 12. Nanobiotechnology Market Trends Table 13. Nanobiotechnology Market Drivers Table 14. Nanobiotechnology Market Challenges Table 15. Nanobiotechnology Market Restraints Table 16. Global Nanobiotechnology Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Nanobiotechnology Market Share by Players (2017-2022) Table 18. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobiotechnology as of 2021) Table 19. Ranking of Global Top Nanobiotechnology Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Nanobiotechnology Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Nanobiotechnology Product Solution and Service Table 23. Date of Enter into Nanobiotechnology Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Nanobiotechnology Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Nanobiotechnology Revenue Market Share by Type (2017-2022) Table 27. Global Nanobiotechnology Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Nanobiotechnology Revenue Market Share by Type (2023-2028) Table 29. Global Nanobiotechnology Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Nanobiotechnology Revenue Market Share by Application (2017-2022) Table 31. Global Nanobiotechnology Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Nanobiotechnology Revenue Market Share by Application (2023-2028) Table 33. North America Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Nanobiotechnology Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Nanobiotechnology Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Nanobiotechnology Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Nanobiotechnology Market Size by Country (2023-2028) & (US$ Million) Table 43. Amgen Company Detail Table 44. Amgen Business Overview Table 45. Amgen Nanobiotechnology Product Table 46. Amgen Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 47. Amgen Recent Development Table 48. Teva Pharmaceuticals Company Detail Table 49. Teva Pharmaceuticals Business Overview Table 50. Teva Pharmaceuticals Nanobiotechnology Product Table 51. Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 52. Teva Pharmaceuticals Recent Development Table 53. Abbott Company Detail Table 54. Abbott Business Overview Table 55. Abbott Nanobiotechnology Product Table 56. Abbott Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 57. Abbott Recent Development Table 58. UCB Company Detail Table 59. UCB Business Overview Table 60. UCB Nanobiotechnology Product Table 61. UCB Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 62. UCB Recent Development Table 63. Roche Company Detail Table 64. Roche Business Overview Table 65. Roche Nanobiotechnology Product Table 66. Roche Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 67. Roche Recent Development Table 68. Celgene Company Detail Table 69. Celgene Business Overview Table 70. Celgene Nanobiotechnology Product Table 71. Celgene Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 72. Celgene Recent Development Table 73. Sanofi Company Detail Table 74. Sanofi Business Overview Table 75. Sanofi Nanobiotechnology Product Table 76. Sanofi Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 77. Sanofi Recent Development Table 78. Merck & Co Company Detail Table 79. Merck & Co Business Overview Table 80. Merck & Co Nanobiotechnology Product Table 81. Merck & Co Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 82. Merck & Co Recent Development Table 83. Biogen Company Detail Table 84. Biogen Business Overview Table 85. Biogen Nanobiotechnology Product Table 86. Biogen Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 87. Biogen Recent Development Table 88. Stryker Company Detail Table 89. Stryker Business Overview Table 90. Stryker Nanobiotechnology Product Table 91. Stryker Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 92. Stryker Recent Development Table 93. Gilead Sciences Company Detail Table 94. Gilead Sciences Business Overview Table 95. Gilead Sciences NanobiotechnologyProduct Table 96. Gilead Sciences Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 97. Gilead Sciences Recent Development Table 98. Pfizer Company Detail Table 99. Pfizer Business Overview Table 100. Pfizer NanobiotechnologyProduct Table 101. Pfizer Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 102. Pfizer Recent Development Table 103. 3M Company Company Detail Table 104. 3M Company Business Overview Table 105. 3M Company NanobiotechnologyProduct Table 106. 3M Company Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 107. 3M Company Recent Development Table 108. Johnson & Johnson Company Detail Table 109. Johnson & Johnson Business Overview Table 110. Johnson & Johnson NanobiotechnologyProduct Table 111. Johnson & Johnson Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 112. Johnson & Johnson Recent Development Table 113. Smith & Nephew Company Detail Table 114. Smith & Nephew Business Overview Table 115. Smith & Nephew NanobiotechnologyProduct Table 116. Smith & Nephew Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 117. Smith & Nephew Recent Development Table 118. Leadiant Biosciences Company Detail Table 119. Leadiant Biosciences Business Overview Table 120. Leadiant Biosciences NanobiotechnologyProduct Table 121. Leadiant Biosciences Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 122. Leadiant Biosciences Recent Development Table 123. Kyowa Hakko Kirin Company Detail Table 124. Kyowa Hakko Kirin Business Overview Table 125. Kyowa Hakko Kirin NanobiotechnologyProduct Table 126. Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 127. Kyowa Hakko Kirin Recent Development Table 128. Shire Company Detail Table 129. Shire Business Overview Table 130. Shire NanobiotechnologyProduct Table 131. Shire Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 132. Shire Recent Development Table 133. Ipsen Company Detail Table 134. Ipsen Business Overview Table 135. Ipsen NanobiotechnologyProduct Table 136. Ipsen Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 137. Ipsen Recent Development Table 138. Endo International Company Detail Table 139. Endo International Business Overview Table 140. Endo International NanobiotechnologyProduct Table 141. Endo International Revenue in Nanobiotechnology Business (2017-2022) & (US$ Million) Table 142. Endo International Recent Development Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Global Nanobiotechnology Market Share by Type: 2021 VS 2028 Figure 2. Nanomedicine Features Figure 3. Nano Medical Devices Features Figure 4. Nano Diagnosis Features Figure 5. Other Features Figure 6. Global Nanobiotechnology Market Share by Application in 2021 & 2028 Figure 7. Anticancer Case Studies Figure 8. CNS Product Case Studies Figure 9. Anti-infective Case Studies Figure 10. Other Case Studies Figure 11. Nanobiotechnology Report Years Considered Figure 12. Global Nanobiotechnology Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Nanobiotechnology Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Nanobiotechnology Market Share by Region: 2021 VS 2028 Figure 15. Global Nanobiotechnology Market Share by Players in 2021 Figure 16. Global Top Nanobiotechnology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanobiotechnology as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Nanobiotechnology Revenue in 2021 Figure 18. North America Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Nanobiotechnology Market Share by Country (2017-2028) Figure 20. United States Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Nanobiotechnology Market Share by Country (2017-2028) Figure 24. Germany Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Nanobiotechnology Market Share by Region (2017-2028) Figure 32. China Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Nanobiotechnology Market Share by Country (2017-2028) Figure 40. Mexico Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Nanobiotechnology Market Share by Country (2017-2028) Figure 44. Turkey Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Nanobiotechnology Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Amgen Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 47. Teva Pharmaceuticals Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 48. Abbott Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 49. UCB Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 50. Roche Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 51. Celgene Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 52. Sanofi Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 53. Merck & Co Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 54. Biogen Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 55. Stryker Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 56. Gilead Sciences Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 57. Pfizer Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 58. 3M Company Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 59. Johnson & Johnson Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 60. Smith & Nephew Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 61. Leadiant Biosciences Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 62. Kyowa Hakko Kirin Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 63. Shire Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 64. Ipsen Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 65. Endo International Revenue Growth Rate in Nanobiotechnology Business (2017-2022) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Amgen Teva Pharmaceuticals Abbott UCB Roche Celgene Sanofi Merck & Co Biogen Stryker Gilead Sciences Pfizer 3M Company Johnson & Johnson Smith & Nephew Leadiant Biosciences Kyowa Hakko Kirin Shire Ipsen Endo International